Dissemination research in cancer control: where are we and where should we go?

ISSN： 0957-5243

Source： Cancer Causes and Control, Vol.20, Iss.4, 2009-05, pp. : 473-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pheochromocytoma – where are we? Where should we go? A medical and scientific odyssey: Review

By Neumann Hartmut Opocher Giuseppe Januszewicz Andrzej Eng Charis

Familial Cancer, Vol. 4, Iss. 1, 2005-03 ,pp. : 1-1

Springer Publishing Company

Access to resources Recommend Favorite

Antibiofilm agents and implant-related infections in orthopaedics: where are we?

By Roman? Carlo L

Journal of Chemotherapy, Vol. 25, Iss. 2, 2013-04 ,pp. : 67-80

Maney Publishing

Access to resources Recommend Favorite

Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

By Katz Matthew

Annals of Surgical Oncology, Vol. 18, Iss. 3, 2011-03 ,pp. : 608-610

Springer Publishing Company

Access to resources Recommend Favorite

Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

By Persiani Roberto

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1077-1079

Springer Publishing Company

Access to resources Recommend Favorite

Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery?

By Leff Daniel

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 607-625

Springer Publishing Company

Access to resources Recommend Favorite